Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 151 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Mikhailidis, Dimitri P [Clear All Filters]
(2013).
The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!.
Curr Med Res Opin. 30(9), 1701-5.
(2014). Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI..
Nat Rev Nephrol. 10(1), 8-9.
(2014). Acute pancreatitis in pregnancy: an overview..
Eur J Obstet Gynecol Reprod Biol. 159(2), 261-6.
(2011). Adrenal incidentaloma: a diagnostic challenge..
Hormones (Athens). 8(3), 163-84.
(2009). Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?.
Curr Opin Cardiol. 25(4), 406-10.
(2010). Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance..
Circ J. 75(8), 2027; author reply 2028.
(2011). Alcohol consumption and the heart..
Int J Cardiol. 168(4), 4319.
(2013). Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?.
Expert Opin Pharmacother. 8(5), 529-35.
(2007). Anti-inflammatory effects of fibrates: an overview..
Curr Med Chem. 16(6), 676-84.
(2009). Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?.
Expert Opin Investig Drugs. 17(7), 969-72.
(2008). Are statins 'IDEAL' for non-alcoholic fatty liver disease?.
Curr Med Res Opin. 30(2), 229-31.
(2014). Are we getting to lipid targets in real life?.
Arch Med Sci. 6(5), 639-41.
(2010). Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study..
Curr Med Res Opin. 27(8), 1659-68.
(2011). Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, CHD, stroke, and peripheral arterial disease in a Mediterranean cohort..
Angiology. 58(6), 689-97.
(2007). Association of reduced zinc status with angiographically severe coronary atherosclerosis: a pilot study..
Angiology. 61(5), 449-55.
(2010). Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?.
Curr Pharm Des. 13(2), 229-39.
(2007). Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients..
Lipids. 42(11), 999-1009.
(2007). Atorvastatin: safety and tolerability..
Expert Opin Drug Saf. 9(4), 667-74.
(2010). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome..
Angiology. 61(1), 49-57.
(2010). Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview..
Curr Vasc Pharmacol. 12(4), 627-41.
(2014). Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?.
Expert Opin Investig Drugs. 17(4), 445-9.
(2008). The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings..
Arch Med Sci. 8(1), 6-10.
(2012). Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis..
J Clin Endocrinol Metab. 94(8), 2692-701.
(2009).